James Ferguson

Company: Matinas BioPharma

Job title: Chief Medical Officer,

Seminars:

Panel Discussion: Looking into the Future: The Next Wave of Lipid-Based Nanocarrier Development 2:00 pm

Why is it important we, as a collective, ensure we’re keeping in-step with the latest nanocarrier constructs What are the critical challenges we’re not addressing in full to progress more candidates through to the clinic leveraging lipid-delivery means? What are the avoidable challenges developers can find they encounter in nanocarrier decision making? Read more

day: Day Two

Extending Our Armamentarium – Physiologically-Targeted Intracellular Delivery Using Phosphatidylserine 3:15 pm

The LNC (Lipid Nano-Crystal) delivery platform – what it potentially adds to the current landscape of lipid-based nanoparticle delivery The complex physiology of phosphatidylserine in lipid membranes – as both surface marker for efferocytotic clearance and as an active contributor to membrane fusion In vitro and in vivo experience to date with the LNC platform…Read more

day: Day Two